v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Product sales, net $ 1,622,246 $ 2,853,813 $ 5,856,351 $ 9,066,550
Cost of products sold 1,742,451 1,044,540 3,326,341 3,320,411
Gross profit (loss) (120,205) 1,809,273 2,530,010 5,746,139
Selling, general and administrative expenses 2,886,081 3,205,996 8,748,485 8,996,092
Research and development expenses 1,500 16,884 215,655 241,964
Impairment to long lived assets 1,539,794 1,539,794
Total operating expenses 4,427,375 3,222,880 10,503,934 9,238,056
Loss from operations (4,547,580) (1,413,607) (7,973,924) (3,491,917)
Other expenses (1,784) (1,046) (5,239) (3,278)
Interest income 1,544 3,582 6,135 6,495
Loss before provision for income taxes and equity in net losses of equity investments (4,547,820) (1,411,071) (7,973,028) (3,488,700)
Provision for income taxes (1,622) (6,475) (17,160) (18,339)
Loss before equity in net losses of equity investments (4,549,442) (1,417,546) (7,990,188) (3,507,039)
Net loss (4,404,565) (1,417,546) (7,729,937) (3,535,980)
Net loss attributable to noncontrolling interests 11,742 6,605 118,424 138,915
Net loss attributable to Milestone Scientific Inc. $ (4,392,823) $ (1,410,941) $ (7,611,513) $ (3,397,065)
Net loss per share applicable to common stockholders—        
Basic (in dollars per share) $ (0.12) $ (0.04) $ (0.22) $ (0.10)
Diluted (in dollars per share) $ (0.12) $ (0.04) $ (0.22) $ (0.10)
Weighted average shares outstanding and to be issued—        
Basic (in shares) 35,586,995 33,573,676 35,086,822 32,501,221
Diluted (in shares) 35,586,995 33,573,676 35,086,822 32,501,221
Milestone Education [Member]        
(Loss) Earnings on earnings from equity method investment $ 1,635 $ 1,635
China Joint Venture [Member]        
(Loss) Earnings on earnings from equity method investment $ 143,242 $ 258,616 $ (28,941)

Source